Daniel Adelman

Dr. Daniel Adelman is a Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. His primary affiliation is with UCSF, where he holds an academic rank of Professor. He completed his M.D. at the University of California Davis School of Medicine in 1983.

His research focuses on Allergy and Immunology, with particular expertise in food allergy management, immunotherapy, and celiac disease. He has also contributed to studies on asthma, immunodeficiency disorders, and drug therapies for vascular diseases. His work spans clinical trials, patient-reported outcomes, and translational research.

Dr. Adelman’s recent articles highlight advancements in peanut immunotherapy safety, eosinophilic esophagitis during trials, and celiac disease symptom tracking. He has led or collaborated on pivotal studies such as the AR101 peanut allergy trials and investigations into latiglutenase for celiac disease.

His contributions extend to clinical guidelines, including updates to food allergy grading scales and management strategies. Though no explicit awards are listed, his extensive publication record reflects recognition in his field.